Avinger has reported that it will present the CONNECT II clinical trial results at the Vascular Interventional Advances (VIVA) conference being held in Las Vegas, Nevada, US, between 9-12 October 2012. The prospective, multi-center, ...
Sunshine Heart has completed two-year follow-up mark for first patient who was implanted with the C-Pulse Heart Assist System in the North America feasibility trial. According to the results from the first patient, it was observed that ...
Tags: Sunshine Heart, two-year follow-up mark, C-Pulse system
Cardiovascular Systems has completed enrolling 443 patients in the ORBIT II trial of its electric orbital atherectomy system(OAS),designed to treat severe calcified coronary arteries. The first premarket approval(PMA)trial,which is ...
Tags: cardiovascular system, OAS, severe calcified coronary arteries, ORBIT II
Boston Scientific has obtained the CE mark approval for the extended longevity provided by its INCEPTA, ENERGEN, PUNCTUA, COGNIS and TELIGEN implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators ...
St Jude Medical has unveiled a real-time cardiac navigation and visualization technology to evaluate vascular and cardiac anatomy on a recorded fluoroscopic image instead of live fluoroscopy. The three-dimensional MediGuide technology ...
The US Food and Drug Administration (FDA) has cleared TriReme Medical's expanded matrix of sizes for Glider PTCA balloon catheter. Torqueable angioplasty Glider PTCA balloon catheter, which utilizes tip technology, is designed for the ...
Tags: FDA, TriReme, PTCA balloon catheter
Maastricht University Medical Center finds that cardiac patients sleep longer when hospital rooms feature lighting that emulates the day-night cycle using LED and other sources. Philips has developed a hospital-room lighting system called ...
Tags: Market View